Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,382 | 5,390 | 4,698 | 6,475 | 8,490 |
| TOTAL | $5,736 | $5,864 | $5,292 | $6,848 | $9,322 |
| Non-Current Assets | |||||
| PPE Net | 2 | 1 | 1 | 2 | 6 |
| Other Non-Current Assets | 0 | 0 | 3 | 3 | 36 |
| TOTAL | $2 | $1 | $4 | $5 | $42 |
| Total Assets | $5,738 | $5,865 | $5,296 | $6,853 | $9,364 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 253 | 184 | 335 | 320 | 657 |
| Accrued Expenses | 762 | 735 | 1,188 | 929 | 942 |
| TOTAL | $1,015 | $919 | $1,523 | $1,249 | $1,634 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,015 | $919 | $1,523 | $1,249 | $1,634 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,778 | 1,055 | 861 | 510 | 510 |
| Retained earnings | -146,356 | -144,730 | -143,206 | -141,360 | -139,206 |
| TOTAL | $4,723 | $4,946 | $3,773 | $5,604 | $7,730 |
| Total Liabilities And Equity | $5,738 | $5,865 | $5,296 | $6,853 | $9,364 |